Magaldrate

An antacid that neutralizes stomach acid by reacting with it to form a less acidic salt. it also forms a protective barrier over the stomach lining.

Simethicone

An anti-foaming agent that helps break down gas bubbles in the stomach and intestines, reducing bloating and discomfort.

Relief of heartburn, indigestion, and acid reflux.

Treatment of symptoms associated with peptic ulcer disease.

Reduction of bloating and gas.

Management of dyspepsia (indigestion).

Megade Oral Suspension (Magaldrate + Simethicone) works by combining the acid-neutralizing properties of magaldrate with the gas-reducing action of simethicone. Magaldrate quickly neutralizes stomach acid, while simethicone breaks down gas bubbles, providing relief from various symptoms related to excess stomach acid and gas.

Store at room temperature, away from heat and moisture. Keep out of reach of children.

The recommended dosage varies depending on the specific formulation and the individual patient's needs. Always follow the instructions provided by your doctor or pharmacist.

Typically, the medication is taken orally, usually 1-2 tablets or a measured dose of liquid suspension, as needed or as directed by a healthcare professional.

Constipation.

Diarrhea.

Dry mouth.

Headache.

Dizziness.

Rarely, allergic reactions may occur.

Alcohol Consumption

It is generally advisable to avoid alcohol while taking this medication as it can worsen the symptoms.



While Driving or Operating Machinery

This medication may cause drowsiness or dizziness in some individuals. If affected, avoid driving or operating machinery.



Pregnant & Breastfeeding Women

Consult with your doctor before taking this medication if you are pregnant or breastfeeding. It is generally safe during pregnancy, but it is best to err on the side of caution and discuss it with your healthcare provider.



Children

The safety and efficacy of this medication in children have not been established. Use only as directed by a doctor.



Kidney

No specific considerations for individuals with kidney disease.



Liver

No specific considerations for individuals with liver disease.

Manufacturer's product information.

Drug databases (e.g., PubChem, Drugs.com).

Medical textbooks and journals.

Healthcare professional resources.